ロード中...
Hepatitis C Disease Burden in the United States in the Era of Oral Direct-Acting Antivirals
Oral direct-acting antivirals (DAAs) represent a major advance in hepatitis C virus (HCV) treatment. Along with recent updates in HCV screening policy and expansions in insurance coverage, the treatment demand in the United States is changing rapidly. Our objective was to project the characteristics...
保存先:
| 出版年: | Hepatology |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5035714/ https://ncbi.nlm.nih.gov/pubmed/27015107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28571 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|